| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6043173 | World Neurosurgery | 2016 | 15 Pages |
Abstract
DBS is a cost-effective intervention for patients with advanced PD, but it has a high initial cost compared with BMT. However, DBS reduces pharmacologic treatment costs and should also reduce direct, indirect, and social costs of PD on the long term.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Jaime Eduardo Becerra, Oscar Zorro, Rafael Ruiz-Gaviria, Camilo Castañeda-Cardona, Margarita Otálora-Esteban, Sara Henao, Sergio Navarrete, Juan Carlos Acevedo, Diego Rosselli,